| Trial ID: | L0551 |
| Source ID: | NCT01561222
|
| Associated Drug: |
Calcitriol
|
| Title: |
Effect of Vitamin D Supplement on Osteoprotegin Expression and Disease Progression in Patients With Chronic Kidney Disease Stage 1 and 2
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease Stage 1|Chronic Kidney Disease Stage 2
|
| Interventions: |
DRUG: Calcitriol|DRUG: placebo
|
| Outcome Measures: |
Primary: Osteoprotegin level, To assess the effect of vitamin D supplementation on osteoprotegin level in CKD patients, one year | Secondary: Bone mineral density, To assess the effect of vitamin D supplementation on bone mineral density in patients with CKD stage 1 and 2, one year|vascular calcification score, To assess the effect of vitamin D supplementation on vascular calcification score through performing lateral abdominal radiography or CT-based techniques in patients with CKD stage 1 and 2, one year
|
| Sponsor/Collaborators: |
Sponsor: Taixing People's Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
300
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION
|
| Start Date: |
2015-07
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2015-06-08
|
| Locations: |
Taixing People's Hospital, Taixing, Jiangsu, 225400, China
|
| URL: |
https://clinicaltrials.gov/show/NCT01561222
|
